Neumora Therapeutics Inc banner
N

Neumora Therapeutics Inc
NASDAQ:NMRA

Watchlist Manager
Neumora Therapeutics Inc
NASDAQ:NMRA
Watchlist
Price: 3.14 USD 2.61% Market Closed
Market Cap: $517.4m

Intrinsic Value

The intrinsic value of one NMRA stock under the Base Case scenario is hidden USD. Compared to the current market price of 3.14 USD, Neumora Therapeutics Inc is hidden .

NMRA Intrinsic Value
HIDDEN
Show

Valuation History
Neumora Therapeutics Inc

Intrinsic Value History
Dive into the past to invest in the future

NMRA looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether NMRA usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about NMRA?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is NMRA valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Neumora Therapeutics Inc.

Explain Valuation
Alternatives to NMRA

Fundamental Analysis

Financials
Efficiency

Earnings Waterfall
Neumora Therapeutics Inc

Wall St
Price Targets

Dividends

Neumora Therapeutics Inc
does not pay dividends
Shareholder Yield
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Ownership

NMRA Insider Trading
Buy and sell transactions by insiders

NMRA News

What is the Intrinsic Value of one NMRA stock?

The intrinsic value of one NMRA stock under the Base Case scenario is hidden USD.

Is NMRA stock undervalued or overvalued?

Compared to the current market price of 3.14 USD, Neumora Therapeutics Inc is hidden .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett